Cannabis Bioscience International Holdings (CBIH) Equity Ratio (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Equity Ratio across 4 years of filings, most recently posting 950.21 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 950.21, down 1054.13% year-over-year; the trailing twelve-month figure through Feb 2026 was 950.21 (down 1054.13% YoY), and the FY2025 annual result was 36.5, down 93.36% from the prior year.
• Equity Ratio came in at 950.21 for Q1 2026 at Cannabis Bioscience International Holdings, down from 61.6 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 8.27 in Q4 2023 to a low of 950.21 in Q1 2026.
• The 4-year median for Equity Ratio is 32.64 (2024), against an average of 118.46.
• Across the five-year window, Equity Ratio slumped 38.41% in 2024 and sank 1054.13% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Equity Ratio stood at 8.27 in 2023, then tumbled by 294.87% to 32.64 in 2024, then sank by 88.7% to 61.6 in 2025, then sank by 1442.64% to 950.21 in 2026.
• The last three Equity Ratio figures came in at 950.21 (Q1 2026), 61.6 (Q4 2025), and 65.79 (Q3 2025), per Business Quant data.